BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 21437870)

  • 1. Calcium signaling in systemic lupus erythematosus T cells: a treatment target.
    Kyttaris VC; Zhang Z; Kampagianni O; Tsokos GC
    Arthritis Rheum; 2011 Jul; 63(7):2058-66. PubMed ID: 21437870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease Stage-Specific Pathogenicity of CD138 (Syndecan 1)-Expressing T Cells in Systemic Lupus Erythematosus.
    Liu L; Takeda K; Akkoyunlu M
    Front Immunol; 2020; 11():1569. PubMed ID: 32849532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
    Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
    Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice.
    Yang J; Li Q; Yang X; Li M
    Mol Med; 2015 Apr; 21(1):364-70. PubMed ID: 25902303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of EZH2 Ameliorates Lupus-Like Disease in MRL/lpr Mice.
    Rohraff DM; He Y; Farkash EA; Schonfeld M; Tsou PS; Sawalha AH
    Arthritis Rheumatol; 2019 Oct; 71(10):1681-1690. PubMed ID: 31106974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imatinib and M351-0056 enhance the function of VISTA and ameliorate the development of SLE via IFN-I and noncanonical NF-κB pathway.
    Yang L; Zhang T; Wang P; Chen W; Liu W; He X; Zhang Y; Jin S; Luo Z; Zhang Z; Wang X; Liu J
    Cell Biol Toxicol; 2023 Dec; 39(6):3287-3304. PubMed ID: 37804401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing FLI1 levels in the MRL/lpr lupus mouse model impacts T cell function by modulating glycosphingolipid metabolism.
    Richard EM; Thiyagarajan T; Bunni MA; Basher F; Roddy PO; Siskind LJ; Nietert PJ; Nowling TK
    PLoS One; 2013; 8(9):e75175. PubMed ID: 24040398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of microRNA-448 suppresses CD4
    Zhang J; Guo Y; Sun Y; Chang L; Wang X
    Biochem Biophys Res Commun; 2022 Mar; 596():88-96. PubMed ID: 35121374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
    J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of glutaminolysis ameliorates lupus by regulating T and B cell subsets and downregulating the mTOR/P70S6K/4EBP1 and NLRP3/caspase-1/IL-1β pathways in MRL/lpr mice.
    Zhang X; Wang G; Bi Y; Jiang Z; Wang X
    Int Immunopharmacol; 2022 Nov; 112():109133. PubMed ID: 36113317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
    Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
    Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
    Schmidt T; Paust HJ; Krebs CF; Turner JE; Kaffke A; Bennstein SB; Koyro T; Peters A; Velden J; Hünemörder S; Haag F; Steinmetz OM; Mittrücker HW; Stahl RA; Panzer U
    Arthritis Rheumatol; 2015 Feb; 67(2):475-87. PubMed ID: 25385550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway.
    Gu Z; Tan W; Ji J; Feng G; Meng Y; Da Z; Guo G; Xia Y; Zhu X; Shi G; Cheng C
    Aging (Albany NY); 2016 May; 8(5):1102-14. PubMed ID: 27048648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonizing miR-7 suppresses B cell hyperresponsiveness and inhibits lupus development.
    Wang M; Chen H; Qiu J; Yang HX; Zhang CY; Fei YY; Zhao LD; Zhou JX; Wang L; Wu QJ; Zhou YZ; Zhang W; Zhang FC; Zhang X; Lipsky PE
    J Autoimmun; 2020 May; 109():102440. PubMed ID: 32201226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular Inflammation and Dysfunction in Lupus-Prone Mice-IL-6 as Mediator of Disease Initiation.
    Marczynski P; Meineck M; Xia N; Li H; Kraus D; Roth W; Möckel T; Boedecker S; Schwarting A; Weinmann-Menke J
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptotanshinone ameliorates the pathogenesis of systemic lupus erythematosus by blocking T cell proliferation.
    Du Y; Du L; He Z; Zhou J; Wen C; Zhang Y
    Int Immunopharmacol; 2019 Sep; 74():105677. PubMed ID: 31177018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired dynamic X-chromosome inactivation maintenance in T cells is a feature of spontaneous murine SLE that is exacerbated in female-biased models.
    Jiwrajka N; Toothacre NE; Beethem ZT; Sting S; Forsyth KS; Dubin AH; Driscoll A; Stohl W; Anguera MC
    J Autoimmun; 2023 Sep; 139():103084. PubMed ID: 37399593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial Dysfunction in the Liver and Antiphospholipid Antibody Production Precede Disease Onset and Respond to Rapamycin in Lupus-Prone Mice.
    Oaks Z; Winans T; Caza T; Fernandez D; Liu Y; Landas SK; Banki K; Perl A
    Arthritis Rheumatol; 2016 Nov; 68(11):2728-2739. PubMed ID: 27332042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of FcγRIIB regulates downstream protein phosphorylation and suppresses B cell activation to ameliorate systemic lupus erythematosus.
    Sheng L; Cao X; Chi S; Wu J; Xing H; Liu H; Yang Z
    Int J Mol Med; 2020 Oct; 46(4):1409-1422. PubMed ID: 32945349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-23 Limits the Production of IL-2 and Promotes Autoimmunity in Lupus.
    Dai H; He F; Tsokos GC; Kyttaris VC
    J Immunol; 2017 Aug; 199(3):903-910. PubMed ID: 28646040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.